VERA Q4 2024 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$49M

Net Income

-$43M

EPS (Diluted)

$-0.85

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$40M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$656M

Total Liabilities

$79M

Stockholders' Equity

$577M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$635,000	-100.0%
Operating Income	-$49M	-$27M	-81.0%
Net Income	-$43M	-$26M	-69.3%